Trial Profile
Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Metoprolol
- Indications Metabolic syndrome
- Focus Therapeutic Use
- 12 Feb 2012 Results published in Hypertension.
- 06 Sep 2011 Actual end date June 2011 as reported by ClinicalTrials.gov
- 06 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.